Freshness Index 2024: Legacy Drugs Dominate Revenues

 
• By Edwin Elmhirst
  
Hourglass with coins
As blockbuster drugs lose patent protection and sales decline, big pharma companies must replenish aging portfolios. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Business